
NIHR salutes TrialBlazers in new campaign to take part in health and care research
NIHR salutes TrialBlazers in new campaign to take part in health and care research
- Published: 20 May 2022
NIHR salutes TrialBlazers in new campaign to take part in health and care research
An NIHR-funded study led by researchers at the NIHR Leicester Biomedical Research Centre has shown that a less invasive heart procedure for a common condition is just as effective as conventional open-heart surgery. The findings are published in the Journal of the American Medical Association (JAMA).
Antibiotics given to women before a caesarean birth have no effect on the risk of early childhood conditions, such as asthma or eczema, finds an NIHR-funded study.
E-cigarettes are just as safe as nicotine patches for pregnant women and may help more women stop smoking, finds new NIHR-funded research.
New research has revealed children’s physical activity levels in the UK were significantly lower by the time the COVID-19 pandemic public lockdown restrictions were lifted.
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from the NIHR-supported COV-BOOST study.
New research funded by NIHR has found that many parents attending commercial weight management programmes would be happy for their child, if overweight, to also receive support to reach a healthier weight.
Dr Peter McGuigan and Dr Alicia Waite have been awarded Established Clinician and Early Career Clinician by the NIHR CRN and the FICM.
New research funded by NIHR shows that patients who were hospitalised with severe COVID have lasting cognitive problems several months after their acute illness.
Self-monitoring of blood pressure during pregnancy does not help detect high blood pressure earlier, according to the results of a large new clinical trial.
The NIHR is delighted to announce that over 1,000 health and care professionals have now got involved with research for the first time as part of the Associate Principal Investigator (PI) Scheme.
NIHR has co-funded a new £6.4m trial which could pave the way for a test to be established as a routine screening programme to detect Barrett’s oesophagus – a condition that can lead to oesophageal cancer.
Experts are launching a major study to help reduce the likelihood of people in developing countries dying unnecessarily from injuries caused by accidents or violence.
Globally, the prevalence of type 2 diabetes mellitus (T2DM) is increasing. An NIHR-funded study, published in PLOS Medicine, suggests that living near fast food restaurants increases the risk of developing the condition.
Researchers have worked with patients to develop a comprehensive tool to assess the symptoms of long COVID and their impact on everyday life.
The latest results from the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses of several COVID-19 vaccines.
The NIHR is proud to publish our Race Equality Framework - a self-assessment tool to help organisations improve racial equality in public involvement in health and care research.
Following rigorous clinical trials supported by the NIHR and thorough data analysis, the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the Valneva COVID-19 vaccine for UK use.
The NIHR-supported PANORAMIC trial is investigating a new COVID-19 antiviral treatment, Paxlovid, among vulnerable groups in the community.
NIHR has co-funded 14 new research projects to develop technologies such as self-care apps, smart devices and wearables to help people transform their care and health at home.
Experts at Northumbria University are supporting a £1 million research study, funded by the NIHR, which aims to improve the outcomes and experiences of those being discharged from mental health hospitals.
A commonly used means of delivering additional oxygen to children in intensive care is not as effective as many clinicians assume, according to new NIHR-funded research.
The largest ever clinical trial of virtual reality (VR) therapy for mental health, funded by NIHR, has shown that automated VR treatment works well for patients diagnosed with psychosis.
Since its establishment in 2006, the NIHR has invested over £200m in more than 470 social care research projects across its portfolio, with £90m worth of NIHR-funded social care studies starting in the last three years.
Scientists led by an NIHR Research Professor have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours.